Abstract
Colonoscopic surveillance for risk of colorectal cancer (CRC) associated with inflammatory bowel disease (IBD) is recommended annually beginning at 8 years disease duration in ulcerative pancolitis and Crohn’s colitis. Family history of sporadic CRC raises the risk of CRC by twofold, association with primary sclerosing cholangitis by fourfold. Optimized conditions for endoscopy, random and targeted biopsy requirements, and patient information and compliance are essential for success of the surveillance program, as well as experienced endoscopic detection and classification of neoplastic lesions: (a) sporadic lesions (in uninvolved colon) and in involved bowel (b) adenomatous dysplasia-associated lesions or mass (DALM), (c) non-adenoma-like DALM, and (d) flat dysplasia. Endoscopic en bloc resection (with free margins) is recommended for lesions (a and b), whereas sphincter-preserving colectomy for (c) non-adenoma-like DALM and (d) flat dysplasia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Eaden JA, et al. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.
Jess T, et al. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724–9.
Ekbom A, et al. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet. 1990;336:357–9.
Farraye FA, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746–74, 774.e741–4; quiz e712–43.
Bernstein CN, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854–62.
Rutter MD, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–8.
Lutgens MW, et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut. 2008;57:1246–51.
Markowitz J, et al. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis. Am J Gastroenterol. 1997;92:2001–6.
Nuako KW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case–control study. Gastroenterology. 1998;115:1079–83.
Soetikno RM, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56:48–54.
Broome U, et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995;22:1404–8.
Lichtiger S, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330:1841–5.
Dekker E, et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy. 2007;39:216–21.
Kiesslich R, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880–8.
Marion JF, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008;103:2342–9.
van den Broek FJ, et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy. 2011;43:108–15.
Kudo S, et al. Colonoscopic diagnosis and management of nonpolypoid early colorectal cancer. World J Surg. 2000;24:1081–90.
Tanaka S, et al. Aim to unify the narrow band imaging (NBI) magnifying classification for colorectal tumors: current status in Japan from a summary of the consensus symposium in the 79th Annual Meeting of the Japan Gastroenterological Endoscopy Society. Dig Endosc. 2011;23 Suppl 1:131–9.
Rutter MD, et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut. 2004;53:1813–6.
Gumaste V, et al. Benign and malignant colorectal strictures in ulcerative colitis. Gut. 1992;33:938–41.
Odze RD. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol. 1999;94:1746–50.
Hata K, et al. Pitfalls of pit pattern diagnosis in ulcerative colitis-associated dysplasia. Gastroenterology. 2004;126:374–6.
East JE, et al. Comparison of magnified pit pattern interpretation with narrow band imaging versus chromoendoscopy for diminutive colonic polyps: a pilot study. Gastrointest Endosc. 2007;66:310–6.
Farraye FA, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–45.
Rubio CA, et al. Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease. Anticancer Res. 2000;20:4761–4.
Lim CH, et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut. 2003;52:1127–32.
Bernstein CN, et al. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994;343:71–4.
Ullman TA, et al. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol. 2002;97:922–7.
Acknowledgments
The contribution of some cases by Dr. Gerhard Kleber/Aalen, Germany; Dr. Andrej Wagner/Salzburg, Austria; and Dr. Naohisa Yahagi, Keio Univ. Medical School/Tokyo, Japan, and evaluation of histology by Dr. Daniel Neureiter/Salzburg, Austria, are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kiesslich, R. (2014). Chronic Inflammatory Bowel Disease in Remission: Mucosal Neoplasias. In: Berr, F., Oyama, T., Ponchon, T., Yahagi, N. (eds) Early Neoplasias of the Gastrointestinal Tract. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-8292-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8292-5_11
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-8291-8
Online ISBN: 978-1-4614-8292-5
eBook Packages: MedicineMedicine (R0)